The European Biotech News Website
Live Last read · last published · next check
Geneva’s life science industry is bound to western Switzerland's Health Valley ecosystem but is also growing in and of itself. The post Life science industry in Geneva on a roll appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited.…
BIO-Europe 2026 heads to Cologne this November, expanding from three tracks to seven to reach the full biotech and pharma C-suite. The post BIO-Europe 2026: Expanding the scope at Europe’s leading biotech partnering event appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s…
Discover 8 biotech companies in Melbourne, ranging from commercial to preclinical-stage companies, advancing promising technologies. The post Eight biotech companies in Melbourne you should know about appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is…
Labiotech's reader survey reveals what our audience wants, needs, and is interested in for 2026. The post We asked, you answered: Labiotech’s 2026 reader survey results appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and…
Cancer Research Horizons' CBO Tony Hickson discusses why charity and pharma need each other now more than ever. The post How Cancer Research Horizons is building the future of childhood cancer medicines appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is…
Discover how UCB’s pipeline strategy in 2026 is still focused on its core areas of immunology and neurology. The post UCB’s pipeline strategy in 2026: Doubling down on immunology and neurology appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly…
In this article, we take a look at seven clinical-stage biotechs that are fostering R&D in the Duchenne muscular dystrophy therapeutic space. The post Seven biotechs driving progress in Duchenne muscular dystrophy appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author…
The CBO CEO relationship shapes biotech deal success. Discover insights from 19 industry leaders on board alignment and partnering. The post We asked 19 biotech leaders what breaks their deals. It wasn’t the science. appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author…
The top biotech deals of July 2026 were over small molecules, cell therapies, antibodies, RNA therapeutics, vaccines, and AI. The post Top biotech deals in July 2026 appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and…
The CEO of Therorna discusses the science of behind circular RNA and why Western pharma hasn't paid enough attention to what's being built in China. The post Why Western pharma is sleeping on China’s circular RNA revolution appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s…
